rs17170223
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The ENST00000456458.5(NT5C3A):n.*16T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0286 in 1,613,086 control chromosomes in the GnomAD database, including 1,302 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.033 ( 129 hom., cov: 32)
Exomes 𝑓: 0.028 ( 1173 hom. )
Consequence
NT5C3A
ENST00000456458.5 non_coding_transcript_exon
ENST00000456458.5 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.627
Publications
5 publications found
Genes affected
NT5C3A (HGNC:17820): (5'-nucleotidase, cytosolic IIIA) This gene encodes a member of the 5'-nucleotidase family of enzymes that catalyze the dephosphorylation of nucleoside 5'-monophosphates. The encoded protein is the type 1 isozyme of pyrimidine 5' nucleotidase and catalyzes the dephosphorylation of pyrimidine 5' monophosphates. Mutations in this gene are a cause of hemolytic anemia due to uridine 5-prime monophosphate hydrolase deficiency. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and pseudogenes of this gene are located on the long arm of chromosomes 3 and 4. [provided by RefSeq, Mar 2012]
NT5C3A Gene-Disease associations (from GenCC):
- hemolytic anemia due to pyrimidine 5' nucleotidase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.22).
BP6
Variant 7-33035961-A-G is Benign according to our data. Variant chr7-33035961-A-G is described in ClinVar as Benign. ClinVar VariationId is 995643.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.112 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0328 AC: 4975AN: 151870Hom.: 131 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4975
AN:
151870
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0341 AC: 8573AN: 251374 AF XY: 0.0388 show subpopulations
GnomAD2 exomes
AF:
AC:
8573
AN:
251374
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0282 AC: 41151AN: 1461098Hom.: 1173 Cov.: 30 AF XY: 0.0310 AC XY: 22569AN XY: 726882 show subpopulations
GnomAD4 exome
AF:
AC:
41151
AN:
1461098
Hom.:
Cov.:
30
AF XY:
AC XY:
22569
AN XY:
726882
show subpopulations
African (AFR)
AF:
AC:
1834
AN:
33448
American (AMR)
AF:
AC:
605
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
1088
AN:
26126
East Asian (EAS)
AF:
AC:
392
AN:
39638
South Asian (SAS)
AF:
AC:
10571
AN:
86212
European-Finnish (FIN)
AF:
AC:
474
AN:
53384
Middle Eastern (MID)
AF:
AC:
344
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
23691
AN:
1111464
Other (OTH)
AF:
AC:
2152
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1843
3686
5528
7371
9214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1034
2068
3102
4136
5170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0327 AC: 4977AN: 151988Hom.: 129 Cov.: 32 AF XY: 0.0329 AC XY: 2446AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
4977
AN:
151988
Hom.:
Cov.:
32
AF XY:
AC XY:
2446
AN XY:
74300
show subpopulations
African (AFR)
AF:
AC:
2223
AN:
41484
American (AMR)
AF:
AC:
365
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
AC:
143
AN:
3456
East Asian (EAS)
AF:
AC:
97
AN:
5186
South Asian (SAS)
AF:
AC:
578
AN:
4808
European-Finnish (FIN)
AF:
AC:
80
AN:
10584
Middle Eastern (MID)
AF:
AC:
24
AN:
292
European-Non Finnish (NFE)
AF:
AC:
1378
AN:
67908
Other (OTH)
AF:
AC:
80
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
244
488
732
976
1220
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
222
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency Benign:1
Nov 15, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.